L'observance thérapeutique des patients atteints de BPCO au cours de leur réhabilitation pulmonaire (1ère partie)
Stefan Margot, Yann Rivière
Kinésithér Scient 2013,0544:05-12 - 10/06/2013
Plusieurs études ont montré l'importante prévalence de la bronchopneumopathie chronique obstructive (BPCO) à travers le monde, et les coûts liés à cette pathologie augmentent régulièrement. La réhabilitation pulmonaire (RP), une prise en charge dont l'efficacité est prouvée, a pour objectifs d'améliorer la symptomatologie des patients, leur qualité de vie, et de diminuer les exacerbations de la maladie. Malgré les bénéFIces pour les patients, ces derniers font régulièrement preuve d'une observance thérapeutique insufisante pour contrôler leur maladie.
Several studies have shown the signifIcant prevalence of chronic obstructive pulmonary disease (COPD) throughout the world and the costs associated with the disease rise regularly. Pulmonary rehabilitation which has been proven to be effective is aimed at decreasing exacerbations as well as improving patients'symptoms and quality of life. Despite the benefits for patients, compliance has been shown to be insuficient to control their disease.
Several studies have shown the signifIcant prevalence of chronic obstructive pulmonary disease (COPD) throughout the world and the costs associated with the disease rise regularly. Pulmonary rehabilitation which has been proven to be effective is aimed at decreasing exacerbations as well as improving patients'symptoms and quality of life. Despite the benefits for patients, compliance has been shown to be insuficient to control their disease.
